Balanced 1 1 Chemotypes
Balanced 1:1 chemotypes refer to cannabis cultivars expressing roughly equal ratios of THC and CBD, typically within 5-10% each. This classification emerged as breeders deliberately crossed high-THC and high-CBD lineages to explore cannabinoid interaction profiles. Chemotype designation relies on laboratory cannabinoid profiling rather than visual or aromatic traits, making it a biochemically-defined category. Balanced ratios represent a distinct breeding objective, separate from THC-dominant or CBD-dominant cultivar development. Lineage records frequently report this chemotype among therapeutic-focused breeding programs and research strains.
Balanced 1 1 Chemotypes strains
No strains tagged into Balanced 1 1 Chemotypes yet — they'll appear here as breeders submit lineage records under this classification.
Balanced 1:1 chemotypes refer to cannabis cultivars expressing roughly equal ratios of THC and CBD, typically within 5-10% each. This classification emerged as breeders deliberately crossed high-THC and high-CBD lineages to explore cannabinoid interaction profiles. Chemotype designation relies on laboratory cannabinoid profiling rather than visual or aromatic traits, making it a biochemically-defined category. Balanced ratios represent a distinct breeding objective, separate from THC-dominant or CBD-dominant cultivar development. Lineage records frequently report this chemotype among therapeutic-focused breeding programs and research strains.
Breeders pursuing 1:1 chemotypes typically employ backcrossing or F1 hybridization strategies between established high-THC and high-CBD parents, requiring multiple generations of testing to stabilize the ratio. This chemotype category drives research into cannabinoid synergy and represents a specific commercial niche distinct from single-cannabinoid-focused cultivar lines.
Educational reference · Cultivar metadata only · No medical claims